Observe Medical
高管
查看带有其 7 名主要高管的组织结构图
Observe Medical 搜索最多的简介
- Jorgen Mann, Interim Chief Executive Officer and Chief Commercial ...
- Line Tønnessen, Board Member
- Terje Bakken, Chairman of the Board
高管在Observe Medical变化
- Per Arne Nygard, Chief Financial Officer, 已经离开公司 (新闻发布的2024三月22号).
- Johan Fagerli 曾任 Finance Manager, 现任 Interim Chief Financial Officer (新闻发布的2024三月22号).
- Jorgen Mann 曾任 Chief Commercial Officer, 现升职为 Interim Chief Executive Officer and Chief Commercial Officer (新闻发布的2024三月1号).
创建提醒
跟踪 Observe Medical 的高管变动
生物技术
Navamedic 拥有 2,325 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
- Trace Neuroscience 刚刚宣布为 101 筹款数百万美元。 (公布2024十一月14号).
- AvenCell Therapeutics 刚刚宣布为 112 筹款数百万美元。 (公布2024十一月11号).
生物技术 行业的其他推荐联系人
消息
Observe Medical 的最新新闻稿
- Observe Medical – DOC (Declaration of Conformity) signed for UnoMeter[TM ]Safeti[TM] Plus and subscription form for equity investment received from industrial partner
- Observe Medical – First order from South America
- OBSERVE MEDICAL ASA: Mandatory notification of trade – grant of share options to primary insider
- OBSERVE MEDICAL ASA: First half year report 2024
- Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A
- Observe Medical ASA: Extraordinary general meeting held on 17 July 2024
- Observe Medical ASA: Redelivery of lent shares to person closely associated with primary insider and mandatory notification of trade
- Observe Medical ASA: New share capital registered
- Allocation of offer shares to primary insiders and close associates, disclosure of share lending by person closely associated with a primary insider and mandatory notification of trade
- Jørgen Mann appointed permanent CEO of Observe Medical
- View more press releases Close
通过电子邮件
